Zepbound (tirzepatide) - Eli Lilly
Peer Referral Pathways and 6-Month Outcomes in a Tirzepatide-Supported Digital Weight Loss Service: Retrospective Cohort Study. (PubMed, J Med Internet Res) - Sep 29, 2026 - "In a retrospective analysis of 34,449 adults using an unsubsidized, tirzepatide-supported digital weight loss service (DWLS) in Australia, patients entering via peer referral showed higher 6-month program adherence and greater percentage weight loss than propensity score-matched nonreferred patients, suggesting that peer referral pathways may support retention and effectiveness in medicated obesity care." 
Journal • Retrospective data • Genetic Disorders • Obesity
http://www.ncbi.nlm.nih.gov/pubmed/42804756
 
Jason Hom; Laura Swinckels; Louis Talay; Marilyn Tan; Neera Ahuja
 
Sep 29, 2026
 
Prev Next